4/A: Aspen Aerogels CFO Corrects Stock Ownership Filing

Sentiment:

Insider Transaction Amendment


Aspen Aerogels' CFO, Grant Douglas Thoele, filed an amended Form 4 to correct previously reported beneficial ownership of company stock and restricted stock units.

Summary

  • Grant Douglas Thoele, CFO & Treasurer of Aspen Aerogels Inc. (ASPN), filed a Form 4/A amendment.
  • The amendment corrects the total number of securities beneficially owned following a transaction on October 1, 2025.
  • The original filing on October 3, 2025, did not include 10,511 restricted stock units (RSUs) granted prior to the October 1, 2025, transaction date.
  • On October 1, 2025, Thoele acquired 10,273 Restricted Stock Units (RSUs) at a price of $0.
  • Each RSU represents the right to receive one share of Common Stock upon vesting.
  • The RSUs vest in three equal tranches: one-third on March 5, 2026, one-third on March 5, 2027, and the final one-third on March 5, 2028.
  • Following the corrected transaction, Thoele beneficially owns a total of 25,392 securities directly.
  • This total consists of 4,608 shares of Common Stock and 20,784 RSUs.

Sentiment

Score: 5

Explanation: The filing is an administrative correction of previously reported beneficial ownership, indicating no direct positive or negative operational or financial news. The underlying RSU grant is a standard compensation practice.

Positives

  • The acquisition of 10,273 Restricted Stock Units (RSUs) by the CFO aligns management's interests with shareholder value through future equity participation.
  • The vesting schedule for the RSUs provides a long-term incentive for the CFO, with shares vesting over three years until March 2028.

Negatives

  • The need for an amendment to correct previously reported beneficial ownership indicates an administrative error in the initial filing.

Future Outlook

The vesting schedule for the Restricted Stock Units (RSUs) indicates future equity grants will convert to common stock for the CFO on March 5, 2026, March 5, 2027, and March 5, 2028.

Industry Context

This filing is an administrative update regarding an insider's equity holdings and does not provide information directly related to broader industry trends or competitive positioning for Aspen Aerogels.

Stakeholder Impact

  • Shareholders: Provides updated and accurate transparency regarding the beneficial ownership of a key executive, which can foster trust and confidence in corporate disclosures.

Next Steps

  • Vesting of one-third of the Restricted Stock Units on March 5, 2026.
  • Vesting of an additional one-third of the Restricted Stock Units on March 5, 2027.
  • Vesting of the final one-third of the Restricted Stock Units on March 5, 2028.

Key Dates

DateDescription
10/01/2025Date of earliest transaction (acquisition of RSUs)
10/03/2025Date of original Form 4 filing
12/19/2025Date of Form 4/A amendment filing
03/05/2026Vesting date for one-third of the acquired Restricted Stock Units
03/05/2027Vesting date for an additional one-third of the acquired Restricted Stock Units
03/05/2028Vesting date for the remaining one-third of the acquired Restricted Stock Units

Recommendation

hold

This filing is an administrative correction of an insider's beneficial ownership and does not provide new information that would alter the fundamental investment thesis for Aspen Aerogels. Therefore, a 'hold' recommendation is appropriate as it neither signals a significant positive nor negative development for the company's operational or financial performance.

Keywords

Aspen Aerogels, ASPN, Form 4/A, Insider Transaction, Beneficial Ownership, Restricted Stock Units, RSU, CFO, Grant Douglas Thoele

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.